je.st
news
Tag: drug
Allegheny Health Network Researchers Receive Federal Grant To Explore Potential Of Drug For Type 2 Diabetes
2015-12-16 01:16:14| drugdiscoveryonline Home Page
Could a drug initially developed to treat chronic obstructive pulmonary disease (COPD) be useful in treating type 2 diabetes? Allegheny Health Network’s Institute of Cellular Therapeutics has received a $2.2M grant from the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) to explore that possibility.
Tags: type
health
receive
network
Merck wins approval for long-delayed surgery revival drug
2015-12-16 00:13:16| Biotech - Topix.net
Federal health authorities have approved a new drug that helps patients recover from the numbing effects of certain surgical drugs. The approval of Bridion marks a victory for Merck & Co.
Tags: drug
approval
surgery
wins
Latest cholesterol drug comes with a $14,600-a-year price tag
2015-12-15 20:26:09| Beverages - Topix.net
Cholesterol-controlling drug Praluent's not a college education, but with a potential lifelong dosage requirement, the new drug could easily cost as much or more. So consumers with high cholesterol may have thought they had cause to cheer Friday's news that Praluent-approved by the U.S. Food and Drug Administration just this summer-would be covered by health-care industry giant UnitedHealth Group Inc. But while all men may be created equal, not everyone with high-cholesterol-or their insurance plan -- is.
The racket behind Pfizer's new $9,850 breast cancer drug
2015-12-12 11:33:08| Biotech - Topix.net
Laura Robison of Minneapolis used crowdfunding to help pay for Ibance, a breast cancer treatment drug that hit the market less than a year ago. Robison's disease is Stage 3. She's seeking donations to cover her medical expenses, which add up fast considering the monthly cost for Ibance is almost $10,000.
Tags: drug
cancer
breast
racket
FDA approves Genentech drug for advanced lung cancer
2015-12-11 23:03:49| Biotech - Topix.net
The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain type of lung cancer who have few other options. Alecensa won accelerated approval for patients with advanced non-small cell lung cancer with a mutation in a gene called ALK who have relapsed after treatment with Pfizer Inc.'s Xalkori or who could not tolerate that drug.
Tags: advanced
drug
cancer
lung
Sites : [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] next »